Product Program year 2025 Source: CMS Open Payments

Optimizer

Device Cardiovascular Device

PDI 00810003380050

Open in the dashboard

General payments

$4,053,226

24,076 payments

Research payments

$1,650,393

661 payments

Through program year 2025, $4,053,226 in general payments and $1,650,393 in research payments were reported against Optimizer (Cardiovascular Device).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $887,717 4,506
2024 General $1,296,307 6,539
2023 General $1,862,519 12,866
2023 Research $997,841 476
2022 General $6,683 165
2021 Research $652,552 185

Breakdown

Who paid General payments · program years 2022–2025
  1. Impulse Dynamics (USA) Inc. $4,053,226 24,076 payments
Top recipients General payments · program year 2025
  1. Daniel Burkhoff Saddlebrook, NJ $110,000 12% · 11 payments
  2. Nancy Bonnet Nurse Practitioner · Morristown, NJ $91,762 10% · 36 payments
  3. Javed Butler Advanced Heart Failure and Transplant Cardiology · Jackson, MS $60,979 7% · 6 payments
  4. Rami Kahwash Advanced Heart Failure and Transplant Cardiology · Columbus, OH $45,948 5% · 37 payments
  5. Gregg Stone Cardiovascular Disease · New York, NY $40,000 5% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Advanced Heart Failure and Transplant Cardiology Internal Medicine $176,322 24% · 129 practitioners
  2. Cardiovascular Disease Internal Medicine $157,847 22% · 531 practitioners
  3. Nurse Practitioner $125,510 17% · 155 practitioners
  4. Clinical Cardiac Electrophysiology Internal Medicine $115,600 16% · 338 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $30,961 4% · 226 practitioners

The top 5 of 46 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $137,717 16% · 137 recipients
  2. New Jersey $119,742 13% · 248 recipients
  3. Pennsylvania $77,314 9% · 259 recipients
  4. Ohio $63,335 7% · 41 recipients
  5. Mississippi $62,332 7% · 5 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

24,076 general · 661 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record